Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-24

Clinical Trial Update: Evaluation of Surfactant Protein B in the Differential Diagnostics of Dyspnea

View source ↗

Summary

A completed clinical trial evaluated the use of Surfactant Protein B to aid differential diagnosis of dyspnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Surfactant Protein B (Surfactant Protein B)

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Dyspnea, Cardiac Disease | Status: COMPLETED